Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) Piotroski F-Score: 4 (As of Jul. 28, 2026) — 20% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603392 Beijing Wantai Biological Pharmacy Enterprise Co Ltd SHSE:603392
53 GF Score
Price ¥29.20
GF Value ¥42.09
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Beijing Wantai Biological Pharmacy Enterprise Co Piotroski F-Score?

Beijing Wantai Biological Pharmacy Enterprise Co SHSE:603392 +0.17% 53 Piotroski F-Score is 4 as of Jul. 28, 2026, which is 20% below its 10-year median of 5.00. GuruFocus rates SHSE:603392 with a GF Score™ of 53/100 and a GF Value™ of ¥42.09 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,331 Biotechnology companies, Beijing Wantai Biological Pharmacy Enterprise Co ranks better than 73.93% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Beijing Wantai Biological Pharmacy Enterprise Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Beijing Wantai Biological Pharmacy Enterprise Co's Piotroski F-Score or its related term are showing as below:

SHSE:603392' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 8
Current: 4

During the past 13 years, the highest Piotroski F-Score of Beijing Wantai Biological Pharmacy Enterprise Co was 8. The lowest was 2. And the median was 5.

Beijing Wantai Biological Pharmacy Enterprise Co  (SHSE:603392) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Beijing Wantai Biological Pharmacy Enterprise Co Piotroski F-Score Related Terms


Beijing Wantai Biological Pharmacy Enterprise Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Beijing Wantai Biological Pharmacy Enterprise Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Wantai Biological Pharmacy Enterprise Co Piotroski F-Score Chart

Beijing Wantai Biological Pharmacy Enterprise Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 5.00 6.00 4.00 5.00

Beijing Wantai Biological Pharmacy Enterprise Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 3.00 3.00 5.00 4.00

SHSE:603392 vs VRTX, REGN, RVMD: Piotroski F-Score Comparison

For the Biotechnology subindustry, Beijing Wantai Biological Pharmacy Enterprise Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Wantai Biological Pharmacy Enterprise Co Piotroski F-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Wantai Biological Pharmacy Enterprise Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Beijing Wantai Biological Pharmacy Enterprise Co's Piotroski F-Score falls into.


SHSE:603392
53GF Score
Beijing Wantai Biological Pharmacy Enterprise Co Ltd SHSE:603392
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -91.261 + -29.384 + -224.846 + -42.984 = ¥-388 Mil.
Cash Flow from Operations was 19.42 + 73.838 + 82.469 + -232.044 = ¥-56 Mil.
Revenue was 442.937 + 654.808 + 320.598 + 523.345 = ¥1,942 Mil.
Gross Profit was 242.487 + 293.746 + 94.285 + 365.597 = ¥996 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(14469.838 + 14240.506 + 14370.758 + 14044.057 + 13760.997) / 5 = ¥14177.2312 Mil.
Total Assets at the begining of this year (Mar25) was ¥14,470 Mil.
Long-Term Debt & Capital Lease Obligation was ¥106 Mil.
Total Current Assets was ¥6,731 Mil.
Total Current Liabilities was ¥1,598 Mil.
Net Income was 134.772 + 6.169 + -160.414 + -52.777 = ¥-72 Mil.

Revenue was 613.532 + 582.066 + 297.292 + 400.625 = ¥1,894 Mil.
Gross Profit was 422.754 + 374.182 + 162.975 + 266.622 = ¥1,227 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(15555.283 + 14962.382 + 14739.373 + 14689.396 + 14469.838) / 5 = ¥14883.2544 Mil.
Total Assets at the begining of last year (Mar24) was ¥15,555 Mil.
Long-Term Debt & Capital Lease Obligation was ¥168 Mil.
Total Current Assets was ¥7,629 Mil.
Total Current Liabilities was ¥1,844 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Beijing Wantai Biological Pharmacy Enterprise Co's current Net Income (TTM) was -388. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Beijing Wantai Biological Pharmacy Enterprise Co's current Cash Flow from Operations (TTM) was -56. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-388.475/14469.838
=-0.02684723

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-72.25/15555.283
=-0.00464472

Beijing Wantai Biological Pharmacy Enterprise Co's return on assets of this year was -0.02684723. Beijing Wantai Biological Pharmacy Enterprise Co's return on assets of last year was -0.00464472. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Beijing Wantai Biological Pharmacy Enterprise Co's current Net Income (TTM) was -388. Beijing Wantai Biological Pharmacy Enterprise Co's current Cash Flow from Operations (TTM) was -56. ==> -56 > -388 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=105.6/14177.2312
=0.00744856

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=168.146/14883.2544
=0.01129766

Beijing Wantai Biological Pharmacy Enterprise Co's gearing of this year was 0.00744856. Beijing Wantai Biological Pharmacy Enterprise Co's gearing of last year was 0.01129766. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=6730.936/1598.065
=4.2119288

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=7629.26/1844.367
=4.13651947

Beijing Wantai Biological Pharmacy Enterprise Co's current ratio of this year was 4.2119288. Beijing Wantai Biological Pharmacy Enterprise Co's current ratio of last year was 4.13651947. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Beijing Wantai Biological Pharmacy Enterprise Co's number of shares in issue this year was 1432.794. Beijing Wantai Biological Pharmacy Enterprise Co's number of shares in issue last year was 1319.424. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=996.115/1941.688
=0.51301496

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1226.533/1893.515
=0.64775457

Beijing Wantai Biological Pharmacy Enterprise Co's gross margin of this year was 0.51301496. Beijing Wantai Biological Pharmacy Enterprise Co's gross margin of last year was 0.64775457. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=1941.688/14469.838
=0.13418865

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=1893.515/15555.283
=0.1217281

Beijing Wantai Biological Pharmacy Enterprise Co's asset turnover of this year was 0.13418865. Beijing Wantai Biological Pharmacy Enterprise Co's asset turnover of last year was 0.1217281. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+1+0+0+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Beijing Wantai Biological Pharmacy Enterprise Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) has a Piotroski F-Score of 4 as of Jul. 28, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Beijing Wantai Biological Pharmacy Enterprise Co and its competitors. This is 20% below median its historical median of 5.00. Over the past decade, Beijing Wantai Biological Pharmacy Enterprise Co's Piotroski F-Score has ranged from 2.00 to 8.00. According to the industry distribution chart, Beijing Wantai Biological Pharmacy Enterprise Co ranks #347 out of 1331 companies in the Biotechnology industry, placing it in the top 26.1%.
Is Beijing Wantai Biological Pharmacy Enterprise Co's Piotroski F-Score too high?
Beijing Wantai Biological Pharmacy Enterprise Co's current Piotroski F-Score of 4 is 20% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. The Biotechnology industry median Piotroski F-Score is 3.00. Beijing Wantai Biological Pharmacy Enterprise Co's value of 4 is 33.3% above this industry median. Based on the distribution chart, Beijing Wantai Biological Pharmacy Enterprise Co ranks #347 out of 1331 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Beijing Wantai Biological Pharmacy Enterprise Co has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Beijing Wantai Biological Pharmacy Enterprise Co's Piotroski F-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Beijing Wantai Biological Pharmacy Enterprise Co ranks #347 out of 1331 companies for Piotroski F-Score. This puts Beijing Wantai Biological Pharmacy Enterprise Co in the upper half of its industry. The industry median Piotroski F-Score is 3.00. Beijing Wantai Biological Pharmacy Enterprise Co's value of 4 is 33.3% above this benchmark. Historically, Beijing Wantai Biological Pharmacy Enterprise Co's own Piotroski F-Score has ranged from 2.00 to 8.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 3.00, Beijing Wantai Biological Pharmacy Enterprise Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Biotechnology company?
The median Piotroski F-Score among Biotechnology companies is 3.00, based on 1,331 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Wantai Biological Pharmacy Enterprise Co's current Piotroski F-Score of 4 is 33.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Beijing Wantai Biological Pharmacy Enterprise Co and its competitors. For the Biotechnology industry, the median Piotroski F-Score is 3.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Wantai Biological Pharmacy Enterprise Co's current Piotroski F-Score is 4, which is 20% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Wantai Biological Pharmacy Enterprise Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) is currently considered Possible Value Trap. The stock's GF Value™ is ¥42.09, compared to a current price of ¥29.20 — trading 30.6% below its estimated fair value. The current Piotroski F-Score is 4, which is 20% below median its 10-year median of 5.00 and 33.3% above the Biotechnology industry median of 3.00. Beijing Wantai Biological Pharmacy Enterprise Co's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392), the current Piotroski F-Score is 4 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Wantai Biological Pharmacy Enterprise Co stock appears to be undervalued. The current stock price of ¥29.20 is trading 30.6% below its estimated GF Value™ of ¥42.09. GuruFocus considers Beijing Wantai Biological Pharmacy Enterprise Co to be Possible Value Trap.

Key valuation signals for SHSE:603392:

  • Piotroski F-Score: 4 (20% below median its 10-year median of 5.00)
  • GF Value™: ¥42.09 vs. price of ¥29.20 (30.6% below fair value)
  • GF Score™: 53/100 with 4 warning signs
  • Industry Position: 33.3% above the Biotechnology median (#347 of 1331)

No single metric tells the full story. See the SHSE:603392 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Beijing Wantai Biological Pharmacy Enterprise Co Business Description

Address No. 31, Science Park Road, Changping District, Beijing, CHN, 102206
Beijing Wantai Biological Pharmacy Enterprise Co Ltd is engaged in research, development, production, and sales of in vitro diagnostic reagents, instruments, and vaccines. The company has two segments: Diagnostic and Vaccine. The Diagnostic segment develops and sells in vitro diagnostic reagents such as ELISA, colloidal gold, biochemical, and chemiluminescent kits, along with instruments including chemiluminescent analyzers, fluorescent analyzers, and nucleic acid purification systems. The Vaccine segment focuses on products like the hepatitis E vaccine, the bivalent HPV vaccine, and the nasal spray COVID-19 vaccine. It generates the majority of its revenue from the Diagnostic segment.
53GF Score

Get the complete analysis for SHSE:603392

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥29.20
Price
¥42.09
GF Value